Cargando…

Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report

BACKGROUND: Hepatic encephalopathy is a serious complication of cirrhosis that presents with a variety of neuropsychiatric abnormalities, including disorientation, asterixis, and coma. Seizures are an uncommon and potentially dangerous complication of hepatic encephalopathy. We present a unique case...

Descripción completa

Detalles Bibliográficos
Autores principales: Chowdhury, Aneesa R., Marcus, Erin N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Republic of Macedonia 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560308/
https://www.ncbi.nlm.nih.gov/pubmed/31210820
http://dx.doi.org/10.3889/oamjms.2019.458
_version_ 1783425945326059520
author Chowdhury, Aneesa R.
Marcus, Erin N.
author_facet Chowdhury, Aneesa R.
Marcus, Erin N.
author_sort Chowdhury, Aneesa R.
collection PubMed
description BACKGROUND: Hepatic encephalopathy is a serious complication of cirrhosis that presents with a variety of neuropsychiatric abnormalities, including disorientation, asterixis, and coma. Seizures are an uncommon and potentially dangerous complication of hepatic encephalopathy. We present a unique case of a 42-year-old female with a history of well-controlled seizure disorder suddenly become refractory to anticonvulsant therapy following the development of hepatic encephalopathy secondary to liver decompensation. CASE PRESENTATION: A 42-year-old female presented to our hospital following a seizure accompanied by loss of consciousness, urinary incontinence, and the prolonged postictal state. She reports her seizures were initially well-controlled with Levetiracetam 500 mg twice a day but recently began experiencing seizures every other day despite up-titration of Levetiracetam to 1500 mg twice a day over a few weeks. On arrival, her serum ammonia level was 116 μmol/L. CT brain was negative while CT liver was consistent with cirrhotic morphology. An electroencephalogram revealed irregular, diffuse, delta/theta slowing consistent with mild to moderate encephalopathy. The patient was started on lactulose 40mg and Rifaximin 550 mg twice a day. Her symptoms of disorientation and lethargy resolved over 3 days. CONCLUSION: Though uncommon, hepatic encephalopathy should be considered in patients presenting with convulsions, especially if there is a known history of liver disease. Until the underlying liver issues are addressed, patients may not respond to traditional anti-convulsant therapy for their seizures.
format Online
Article
Text
id pubmed-6560308
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Republic of Macedonia
record_format MEDLINE/PubMed
spelling pubmed-65603082019-06-17 Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report Chowdhury, Aneesa R. Marcus, Erin N. Open Access Maced J Med Sci Case Report BACKGROUND: Hepatic encephalopathy is a serious complication of cirrhosis that presents with a variety of neuropsychiatric abnormalities, including disorientation, asterixis, and coma. Seizures are an uncommon and potentially dangerous complication of hepatic encephalopathy. We present a unique case of a 42-year-old female with a history of well-controlled seizure disorder suddenly become refractory to anticonvulsant therapy following the development of hepatic encephalopathy secondary to liver decompensation. CASE PRESENTATION: A 42-year-old female presented to our hospital following a seizure accompanied by loss of consciousness, urinary incontinence, and the prolonged postictal state. She reports her seizures were initially well-controlled with Levetiracetam 500 mg twice a day but recently began experiencing seizures every other day despite up-titration of Levetiracetam to 1500 mg twice a day over a few weeks. On arrival, her serum ammonia level was 116 μmol/L. CT brain was negative while CT liver was consistent with cirrhotic morphology. An electroencephalogram revealed irregular, diffuse, delta/theta slowing consistent with mild to moderate encephalopathy. The patient was started on lactulose 40mg and Rifaximin 550 mg twice a day. Her symptoms of disorientation and lethargy resolved over 3 days. CONCLUSION: Though uncommon, hepatic encephalopathy should be considered in patients presenting with convulsions, especially if there is a known history of liver disease. Until the underlying liver issues are addressed, patients may not respond to traditional anti-convulsant therapy for their seizures. Republic of Macedonia 2019-05-30 /pmc/articles/PMC6560308/ /pubmed/31210820 http://dx.doi.org/10.3889/oamjms.2019.458 Text en Copyright: © 2019 Aneesa R. Chowdhury, Erin N. Marcus. http://creativecommons.org/licenses/CC BY-NC/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).
spellingShingle Case Report
Chowdhury, Aneesa R.
Marcus, Erin N.
Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report
title Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report
title_full Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report
title_fullStr Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report
title_full_unstemmed Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report
title_short Seizure Disorder Exacerbated by Hepatic Encephalopathy: A Case Report
title_sort seizure disorder exacerbated by hepatic encephalopathy: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560308/
https://www.ncbi.nlm.nih.gov/pubmed/31210820
http://dx.doi.org/10.3889/oamjms.2019.458
work_keys_str_mv AT chowdhuryaneesar seizuredisorderexacerbatedbyhepaticencephalopathyacasereport
AT marcuserinn seizuredisorderexacerbatedbyhepaticencephalopathyacasereport